Glorikian Publications
NextGen Healthcare: The problem isn’t genomics by Harry Glorikian, a…
Listent to Episode Here: http://fticorporate.com/podcasts/harry-glorikian/ Diving with Data – Episode 11:…
What we pay for in healthcare is the real question…
Digital Health Transformation: Telemedicine & Remote Monitoring Every week, news…
MONEYBALL MEDICINE PRICE QUALITY TRANSPARENCY Say you want to open…
Leadership Series: Interview with Harry Glorikian, Partner at New Ventures…
Costs of healthcare rise: Welcome to the age of Moneyball…
Transforming the Bioresearch and Healthcare Industries Technology and Data Usher…
Why do IVD companies face a battle with payers for…
Intellectual property considerations for molecular diagnostic development with emphasis on…
MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market How…
The MoneyBall solution to the healthcare crisis Many recent articles…
IVD Development: What’s the solution to efficient IVD development? In…
Data and IVD’s requirements in a value-based reimbursement landscape The…
pre-design research is essential for the IVD industry It’s an…
How IVD’s industry tap the growth potential of Integrated Delivery…
Learning from failure: What Theranos, Interleukin Genetics, & Courtagen can…
Do You Have the Data to Benefit from a Post-Keytruda…
MDBR Interviews Harry Glorikian About the Growing Significance of In…